SCHEMBL17421908

SCHEMBL17421908

Cc1ccccc1C=CB(O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
TSHR P16473 3/20 0.52
CA1 P00915 4/20 0.50
MGLL Q99685 1/20 0.44
RAB9A P51151 6/20 0.43
KDM4E B2RXH2 5/20 0.43
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PABPC1 P11940 1/20 0.42
CYP1A2 P05177 2/20 0.40
TP53 P04637 1/20 0.40
CYP2D6 P10635 1/20 0.40
THPO P40225 1/20 0.40
HIF1A Q16665 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17421907 1.00 ALDH1A1 (0.52) ALDH1A1TSHRCA1MGLLRAB9A
SCHEMBL29453244 1.00 ALDH1A1 (0.52) ALDH1A1TSHRCA1MGLLRAB9A
SCHEMBL1035353 0.78 ALDH1A1 (0.62) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A
SCHEMBL1589395 0.78 ALDH1A1 (0.62) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A
SCHEMBL1767678 0.76 ALDH1A1 (0.59) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A
SCHEMBL31668810 0.76 ALDH1A1 (0.59) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A
SCHEMBL142259 0.76 ALDH1A1 (0.59) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A
SCHEMBL6397710 0.75 ALDH1A1 (0.52) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A
SCHEMBL20451369 0.75 ALDH1A1 (0.52) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A
SCHEMBL16480312 0.75 ALDH1A1 (0.52) ALDH1A1TSHRRAB9AKDM4EAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021036515-A1 METHOD FOR SYNTHESIZING ALKENYL BORATE COMPOUND 中国科学院兰州化学物理研究所 2021-03-04 WO disclosed
EP-3166918-B1 METAL-CATALYZED ASYMMETRIC 1,4-CONJUGATE ADDITION OF VINYLBORON COMPOUNDS TO 2-SUBSTITUTED-4-OXY- CYCLOPENT-2-EN-1-ONES YIELDING PROSTAGLANDINS AND PROSTAGLANDIN ANALOGS SCINOPHARM TAIWAN LTD (TW) 2019-02-20 EP disclosed
US-9670234-B2 Metal-catalyzed asymmetric 1,4-conjugate addition of vinylboron compounds to 2-substituted-4-oxy-cyclopent-2-en-1-ones yielding prostaglandins and prostaglandin analogs SCINOPHARM TAIWAN, LTD. (TW) 2017-06-06 US disclosed
US-20160009740-A1 METAL-CATALYZED ASYMMETRIC 1,4-CONJUGATE ADDITION OF VINYLBORON COMPOUNDS TO 2-SUBSTITUTED-4-OXY-CYCLOPENT-2-EN-1-ONES YIELDING PROSTAGLANDINS AND PROSTAGLANDIN ANALOGS SCINOPHARM TAIWAN, LTD. (TW) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009740-A1 METAL-CATALYZED ASYMMETRIC 1,4-CONJUGATE ADDITION OF VINYLBORON COMPOUNDS TO 2-SUBSTITUTED-4-OXY-CYCLOPENT-2-EN-1-ONES YIELDING PROSTAGLANDINS AND PROSTAGLANDIN ANALOGS PTGIS, PTGER1, PTGS1 ALDH1A1 307/4885TSHR 3705/4885CA1 1335/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.